Several evidence show an increased number of microglia cells in the CBL of AD patients [239,240,241], as well as in relevant animal models and this cells express Trem2, a gene involved in the resiliency to AD pathogenesis in CNS [242]. The gene discussed is TREM2; the disease is Alzheimer disease.